Physician profile
Michael Driscoll
NPI 1811514805
$4,415.95
in general payments reported to CMS, 2019-2025
11 companies · $511 in 2025
The $511 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.96 · 2021: $3,206 · 2022: $222 · 2023: $294 · 2024: $166 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619 · Travel and Lodging: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.48 |
| Travel and Lodging | $351.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,951.61 | 2021-2023 | Taperloc |
| Mid-Atlantic Surgical Systems, LLC | $1,237.40 | 2021-2023 | |
| Stryker Corporation | $521.45 | 2022-2024 | T2 Alpha, Blueprint Patient Specific Instrumentation, Variax |
| Orthopediatrics Corp. | $406.76 | 2025 | |
| Depuy Synthes Sales INC. | $176.41 | 2022-2025 | Speed, Va-Lcp, Na |
| Endo Pharmaceuticals INC. | $31.61 | 2020-2021 | |
| Pacira Therapeutics, INC. | $29.50 | 2021 | |
| Endo USA, INC. | $20.77 | 2024 | Xiaflex |
| Novo Nordisk INC | $16.22 | 2021 | |
| Smith+Nephew, INC. | $12.21 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Driscoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.